Tango Therapeutics Inc (TNGX)

R&D Expense Growth

12.48%

Quarterly · Period ending:

TNGX logo

TNGX R&D Expense Growth

Latest reported12.48%
TNGX Quarterly R&D Growth (QoQ) (0.00% → 12.48%)
High-resolution chart · PNG

TNGX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tango Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
12.4822%
-0.631%
8.0026%
-4.2477%
-11.6898%
7.3813%
2.0263%
-13.9468%
1.5474%
21.4621%
15.4333%
-5.3085%
2.254%
-3.6162%
1.2072%
21.0732%
-2.4209%
12.4619%
-1.3183%
14.9064%
27.1933%
-0.4182%
16.0746%
16.6053%
2.8368%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.